Efficacy of direct oral anticoagulants on left ventricular thrombus

dc.authoridTURGAY YILDIRIM, OZGE/0000-0002-6731-4958
dc.authoridAYDIN, Fatih/0000-0002-1017-1917
dc.contributor.authorYildirim, Ozge Turgay
dc.contributor.authorAksit, Ercan
dc.contributor.authorAydin, Fatih
dc.contributor.authorAydin, Ayse Huseyinoglu
dc.date.accessioned2025-01-27T20:11:54Z
dc.date.available2025-01-27T20:11:54Z
dc.date.issued2019
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractLeft ventricular thrombus (LVT) is a commonly seen complication of myocardial infarction and it also can be seen because of hypertrophic cardiomyopathies, nonischemic dilated cardiomyopathies, malignancies, and so on. Guidelines suggest the use of warfarin for left ventricular thrombi, but recent case reports show that direct oral anticoagulants (DOACs) are beginning to be used for this complication. DOACs are strong alternatives for warfarin because of their efficacy and safety even though there is no randomized controlled trial that proves the effect of DOACs against LVT. In this article, we gather the case reports of DOACs against left ventricular thrombi in various conditions. Copyright (C) 2019 Wolters Kluwer Health, Inc. All rights reserved.
dc.identifier.doi10.1097/MBC.0000000000000801
dc.identifier.endpage103
dc.identifier.issn0957-5235
dc.identifier.issn1473-5733
dc.identifier.issue3
dc.identifier.pmid30864962
dc.identifier.scopus2-s2.0-85064721395
dc.identifier.scopusqualityQ3
dc.identifier.startpage96
dc.identifier.urihttps://doi.org/10.1097/MBC.0000000000000801
dc.identifier.urihttps://hdl.handle.net/20.500.12428/20770
dc.identifier.volume30
dc.identifier.wosWOS:000472685100002
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofBlood Coagulation & Fibrinolysis
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectapical thrombus
dc.subjectapixaban
dc.subjectdabigatran
dc.subjectleft ventricular thrombus
dc.subjectrivaroxaban
dc.titleEfficacy of direct oral anticoagulants on left ventricular thrombus
dc.typeReview Article

Dosyalar